Treatment of Moderate to Severe Glabellar Lines
NCT04249583
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
botulinum toxin
BIOLOGICAL:
Placebo
Sponsor
Galderma R&D